Autonomic Nervous System Drugs Practice Questions

Q: Which drug is generally considered the first-line treatment for pheochromocytoma?

Phenoxybenzamine. ***Phenoxybenzamine (Correct Answer)*** - **Phenoxybenzamine** is a **non-competitive, non-selective alpha-adrenergic blocker** and is considered the **first-line treatment for pheochromocytoma** to prevent hypertensive crises during surgery. - It **irreversibly blocks** both alpha-1 and alpha-2 adrenergic receptors, leading to **vasodilation** and prevention of catecholamine-induced vasoconstriction. - Its **long duration of action** and irreversible binding make it ideal for pre-operative preparation. *Propranolol (Incorrect)* - **Propranolol** is a **beta-blocker** that should **never be used first** in pheochromocytoma as primary treatment. - Blocking beta-2 receptors can lead to **unopposed alpha-adrenergic vasoconstriction**, potentially causing a **hypertensive crisis**. - Beta-blockers are only introduced **after adequate alpha-blockade** to manage tachycardia and arrhythmias. *Prazosin (Incorrect)* - **Prazosin** is a **selective alpha-1 blocker** and competitive antagonist that may not provide sufficient protection against the massive surge of catecholamines during surgery. - While it can lower blood pressure, its effect is **reversible** and **selective**, making it less reliable than non-selective, irreversible blockers in this critical setting. *Phentolamine (Incorrect)* - **Phentolamine** is a **short-acting, non-selective alpha blocker** typically used for acute management of **hypertensive crises** (e.g., during surgery or in critical care) rather than for pre-operative preparation. - Its **shorter duration of action** requires frequent dosing and makes it less suitable for the sustained alpha-blockade needed in the days leading up to pheochromocytoma surgery.

Q: What do organophosphates inhibit in the human body?

The esteratic site of acetylcholinesterase (AchE). ***The esteratic site of acetylcholinesterase (AchE)*** - Organophosphates are **irreversible inhibitors** that bind covalently to the **esteratic site** (serine hydroxyl group) of acetylcholinesterase. - This binding prevents the enzyme from hydrolyzing **acetylcholine**, leading to its accumulation in the synaptic cleft. - This covalent phosphorylation is the hallmark of organophosphate poisoning. *The anionic site of acetylcholinesterase (AchE)* - The **anionic site** of acetylcholinesterase binds to the **quaternary ammonium group** of acetylcholine, facilitating its orientation for hydrolysis at the esteratic site. - While important for enzyme function, organophosphates do not primarily act by inhibiting this site. - Reversible cholinesterase inhibitors (like edrophonium) interact with both sites but do not form covalent bonds. *Acetylcholine (Ach)* - Organophosphates do not directly inhibit **acetylcholine** itself. - Instead, they inhibit the **enzyme that breaks down acetylcholine** (acetylcholinesterase). - The accumulation of acetylcholine is a **consequence** of enzyme inhibition, not the primary target of organophosphate action. *None of the options* - This option is incorrect because the first option accurately describes the specific site of organophosphate inhibition on acetylcholinesterase.

Q: Which drug used for the common cold has been associated with an increased risk of stroke?

Pseudoephedrine. ***Pseudoephedrine*** - Pseudoephedrine is a **sympathomimetic** that can cause **vasoconstriction**, leading to increased blood pressure and heart rate, which elevates the risk of stroke, especially in susceptible individuals [1, 2, 3]. - Its mechanism of action involves stimulating **alpha- and beta-adrenergic receptors**, producing systemic vasoconstriction that reduces nasal congestion [1]. - **FDA restrictions** were placed on pseudoephedrine sales due to well-documented cardiovascular risks, including **hemorrhagic stroke**, particularly in young women and patients with uncontrolled hypertension [3].*Phenylephrine* - Phenylephrine is also a **sympathomimetic decongestant**, primarily an **alpha-1 adrenergic agonist**, causing vasoconstriction [3]. - While it can theoretically increase blood pressure, its **oral bioavailability is poor** (approximately 38%) due to extensive first-pass metabolism, resulting in less consistent systemic effects compared to pseudoephedrine. - The stroke risk association is **significantly lower** than pseudoephedrine, making it a preferred alternative in many guidelines.*Diphenhydramine* - Diphenhydramine is an **antihistamine with anticholinergic properties** used for allergy symptoms and sedation, not primarily as a decongestant. - It does not have a direct mechanism of action that significantly increases the risk of stroke through vasoconstriction. - May cause drowsiness and anticholinergic side effects, but not associated with acute cardiovascular events like stroke.*Oxymetazoline* - Oxymetazoline is a **topical decongestant** found in nasal sprays, which acts as a direct **alpha-adrenergic agonist**. - While it causes local vasoconstriction, systemic absorption is **minimal with topical use**, and it is less associated with stroke risk compared to oral decongestants like pseudoephedrine. - Main concern is **rebound congestion** (rhinitis medicamentosa) with prolonged use, not cardiovascular events.

Q: Cis-atracurium is preferred over atracurium due to which of the following advantages?

No histamine release. **No histamine release** - **Cis-atracurium** is an isomer of atracurium that causes significantly less **histamine release**, reducing the risk of **hypotension**, **tachycardia**, and **bronchospasm**. - This makes cis-atracurium a safer option, particularly in patients with **cardiovascular instability**, **asthma**, or known **allergies**. *Rapid onset* - While both atracurium and cis-atracurium have a relatively **rapid onset** compared to some other neuromuscular blockers, **cis-atracurium**'s onset is generally slightly slower than atracurium. - Therefore, **rapid onset** is not an advantage of cis-atracurium over atracurium. *Short duration of action* - Both atracurium and cis-atracurium have an **intermediate duration of action**, but **cis-atracurium**'s duration is generally slightly longer than atracurium. - A **shorter duration of action** is not a unique advantage of cis-atracurium over atracurium. *None of the options* - This option is incorrect because **cis-atracurium** does offer a significant advantage over atracurium, specifically its reduced potential for **histamine release**.

Q: Which of the following alpha-blocker drugs is used in the treatment of benign prostatic hyperplasia without producing significant hypotension?

Tamsulosin. ***Tamsulosin*** - Tamsulosin is a **selective alpha-1a adrenergic receptor blocker**, which primarily targets receptors in the **prostate** and bladder neck. - Its selectivity minimizes effects on vascular alpha-1b receptors, thereby *reducing the incidence of orthostatic hypotension* compared to non-selective alpha-blockers. *Doxazosin* - Doxazosin is a **non-selective alpha-1 blocker** that affects both prostatic and vascular smooth muscle, making **hypotension a more common side effect**. - While effective for BPH, it is also used for hypertension, indicating its significant impact on **blood pressure**. *Phentolamine* - Phentolamine is a **non-selective alpha-adrenergic blocker** used in pheochromocytoma and hypertensive crises, but not typically for BPH. - It can cause **significant hypotension** due to its widespread alpha-receptor antagonism. *Terazosin* - Similar to doxazosin, terazosin is a **non-selective alpha-1 blocker** that causes peripheral vasodilation. - This property means it can lead to **symptomatic hypotension**, especially upon initiation of therapy.

Q: Which of the following is a selective beta-1 agonist?

Dobutamine. ***Dobutamine*** - **Dobutamine** is a **selective beta-1 agonist** primarily used to increase **cardiac contractility** and output, making it valuable in cases of **heart failure** or **cardiogenic shock**. - Its selectivity for beta-1 receptors minimizes effects on **beta-2 receptors** in the lungs, reducing the risk of **bronchodilation** or **bronchospasm** compared to non-selective beta agonists. *Terbutaline* - **Terbutaline** is a **beta-2 selective agonist** primarily used as a **bronchodilator** in the treatment of **asthma** and **COPD**, and as a **tocolytic** to delay premature labor. - While it has some beta-1 activity at higher doses, its main therapeutic effect comes from **bronchodilation** via **beta-2 receptors**. *Albuterol* - **Albuterol** is a **short-acting beta-2 selective agonist (SABA)** used for the rapid relief of **bronchospasm** in conditions like **asthma**. - Its primary action is on **beta-2 receptors** in the airways, causing **bronchodilation**, and it has minimal activity on **beta-1 receptors** at therapeutic doses. *Isoetharine* - **Isoetharine** is a **beta-2 selective agonist** historically used as a **bronchodilator**, though it is less selective than newer agents like albuterol. - While predominantly acting on **beta-2 receptors**, it can have some **cardiac effects** (beta-1 stimulation) at higher doses, and has been largely replaced by more selective agents with better safety profiles.

Q: Which alpha-1 blocker is known for having minimal effects on blood pressure?

Tamsulosin. ***Correct: Tamsulosin*** - **Tamsulosin** is a **selective alpha-1A blocker**, primarily targeting alpha-1A receptors in the prostate and bladder neck. - Due to its **uroselective** nature, it causes less systemic vasodilation and thus has **minimal effects on blood pressure** compared to non-selective alpha-1 blockers. - This selectivity makes it the preferred agent for **benign prostatic hyperplasia (BPH)** in patients where blood pressure stability is important. *Incorrect: Prazosin* - **Prazosin** is a **non-selective alpha-1 blocker** that acts on both alpha-1A and alpha-1B receptors in the vasculature. - It commonly causes **postural hypotension** and is often used as an antihypertensive agent, indicating significant blood pressure effects. - Requires dose titration to minimize first-dose hypotension. *Incorrect: Doxazosin* - **Doxazosin** is also a **non-selective alpha-1 blocker** that affects vascular smooth muscle. - It is used for both **benign prostatic hyperplasia (BPH)** and **hypertension**, demonstrating its notable blood pressure-lowering effects. - Longer half-life allows once-daily dosing but maintains significant cardiovascular effects. *Incorrect: Terazosin* - **Terazosin** is another **non-selective alpha-1 blocker** with significant effects on vascular smooth muscle. - Similar to prazosin and doxazosin, it can cause **orthostatic hypotension** and a more pronounced reduction in blood pressure. - Also used for dual indication of BPH and hypertension.

Question 1

Which drug is generally considered the first-line treatment for pheochromocytoma?

Accepted Answer

Phenoxybenzamine

Answer

Prazosin

Answer

Phentolamine

Answer

Propranolol

Question 2

What do organophosphates inhibit in the human body?

Accepted Answer

The esteratic site of acetylcholinesterase (AchE)

Answer

The anionic site of acetylcholinesterase (AchE)

Answer

Acetylcholine (Ach)

Answer

None of the options

Question 3

Which drug used for the common cold has been associated with an increased risk of stroke?

Accepted Answer

Pseudoephedrine

Answer

Diphenhydramine

Answer

Phenylephrine

Answer

Oxymetazoline

Question 4

Cis-atracurium is preferred over atracurium due to which of the following advantages?

Accepted Answer

No histamine release

Answer

Rapid onset

Answer

Short duration of action

Answer

None of the options

Question 5

Which of the following alpha-blocker drugs is used in the treatment of benign prostatic hyperplasia without producing significant hypotension?

Accepted Answer

Tamsulosin

Answer

Doxazosin

Answer

Phentolamine

Answer

Terazosin

Question 6

Which of the following is a selective beta-1 agonist?

Accepted Answer

Dobutamine

Answer

Terbutaline

Answer

Albuterol

Answer

Isoetharine

Question 7

Which alpha-1 blocker is known for having minimal effects on blood pressure?

Accepted Answer

Tamsulosin

Answer

Prazosin

Answer

Doxazosin

Answer

Terazosin

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?